Olaf Hardt R&D Reagents Miltenyi Biotec GmbH Biography Publications Institution JoVE Articles Olaf Hardt has not added a biography. If you are Olaf Hardt and would like to personalize this page please email our Author Liaison for assistance. Publications The Sialyl-glycolipid Stage-specific Embryonic Antigen 4 Marks a Subpopulation of Chemotherapy-resistant Breast Cancer Cells with Mesenchymal Features Breast Cancer Research : BCR. 2015 | Pubmed ID: 26607327 Transcriptional Pathways in CPGI2-Induced Adipocyte Progenitor Activation for Browning Frontiers in Endocrinology. 2015 | Pubmed ID: 26347713 Comparison Between Cold Plasma, Electrochemotherapy and Combined Therapy in a Melanoma Mouse Model Experimental Dermatology. Sep, 2013 | Pubmed ID: 23947672 Highly Sensitive Profiling of CD44+/CD24- Breast Cancer Stem Cells by Combining Global MRNA Amplification and Next Generation Sequencing: Evidence for a Hyperactive PI3K Pathway Cancer Letters. Dec, 2012 | Pubmed ID: 22771536 NeuroD1 후 각 성체에서 터미널 신경 분화를 유도합니다 Proceedings of the National Academy of Sciences of the United States of America. Jan, 2010 | Pubmed ID: 20080708 진 식 분석 지역별 GABAergic 신경 세포의 차이점을 정의합니다 Molecular and Cellular Neurosciences. Nov, 2008 | Pubmed ID: 18725299 Characterization of Peptides Released from Mitochondria: Evidence for Constant Proteolysis and Peptide Efflux The Journal of Biological Chemistry. Jan, 2005 | Pubmed ID: 15556950 인간 종양 이종 이식에서 마우스 세포의 고갈은 크게 대상 세포의 다운 스트림 분석을 향상 David J. Agorku1, Stefan Tomiuk1, Kerstin Klingner2, Stefan Wild1, Silvia Rüberg1, Lisa Zatrieb1, Andreas Bosio1, Julia Schueler2, Olaf Hardt1 1R&D Reagents, Miltenyi Biotec GmbH, 2In vivo Tumorbiology, Oncotest GmbH JoVE 54259 의학
인간 종양 이종 이식에서 마우스 세포의 고갈은 크게 대상 세포의 다운 스트림 분석을 향상 David J. Agorku1, Stefan Tomiuk1, Kerstin Klingner2, Stefan Wild1, Silvia Rüberg1, Lisa Zatrieb1, Andreas Bosio1, Julia Schueler2, Olaf Hardt1 1R&D Reagents, Miltenyi Biotec GmbH, 2In vivo Tumorbiology, Oncotest GmbH JoVE 54259 의학